From Trump's 100 per cent pharma tariff to RBI's stance on repo rates, here's what made headlines
01-Nov-2025•Value Research Team
NPS Swasthya: buy the cover, not the corpus
6 min read•By Aakar Rastogi
Welcome to the New Value Research!
2 min read•By Value Research